Literature DB >> 3604899

Natural history of pulmonary hemodynamics in primary pulmonary hypertension.

N Kanemoto.   

Abstract

To study the relationship between the hemodynamic characteristics and prognosis in PPH, we analyzed the data on patients whose prognosis was well documented from the time of hemodynamic monitoring. Our subjects were 87 patients obtained from a nationwide survey in Japan. PCWPs were obtained in 44 patients and COs were measured in 59 patients. The average age was 33 years (range 14 to 69). Patients were followed prospectively for up to 100 months and were categorized based on the survival period from the time of catheterization. Hemodynamic variables that showed significant differences or prognostic trends were RVedp, pulmonary artery diastolic pressure, PCWP, CI, PVR, and PVR/SVR ratio. The CI correlated with the number of survival months (r = 0.583; p less than 0.01). The hemodynamic state of patients who died suddenly within 1 year from the time of catheterization was no different from those who died of clinical right-sided heart failure. The partial pressure of oxygen of arterial blood was the only variable discriminating sudden deaths from right-sided heart failure deaths (54 +/- 2 vs 66 +/- 4 mm Hg; p less than 0.05). The results of this study indicate that the major determinant of prognosis is right ventricular function and that the CI might be used as a prognostic indicator. In addition, sudden death is more likely to occur in patients with severe hypoxia.

Entities:  

Mesh:

Year:  1987        PMID: 3604899     DOI: 10.1016/0002-8703(87)90510-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Recommendations on the management of pulmonary hypertension in clinical practice.

Authors: 
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

Review 2.  Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy.

Authors:  Jennifer L Snow; Steven M Kawut
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

3.  Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension.

Authors:  Amil M Shah; Patricia Campbell; Gabriela Querejeta Rocha; Andrew Peacock; Robyn J Barst; Debbie Quinn; Scott D Solomon
Journal:  Eur Heart J       Date:  2014-02-23       Impact factor: 29.983

4.  Increased risk of mortality in systemic sclerosis-associated pulmonary hypertension: a systemic review and meta-analysis.

Authors:  Anji Xiong; Qingting Liu; Jiaxun Zhong; Yuzi Cao; Qilang Xiang; Ziyi Hu; Shifeng Zhou; Zhuoyao Song; Huini Chen; Yan Zhang; Hongxu Cui; Shiquan Shuai
Journal:  Adv Rheumatol       Date:  2022-03-30

5.  Right ventricular ejection fraction during exercise as a predictor of mortality in patients awaiting lung transplantation: a cohort study.

Authors:  Nedim Selimovic; Bert Andersson; Odd Bech-Hanssen; Milan Lomsky; Gerdt C Riise; Bengt Rundqvist
Journal:  BMJ Open       Date:  2013-04-08       Impact factor: 2.692

6.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: General management for pulmonary hypertension.

Authors:  Majdy M Idrees; John Swiston; Robert D Levy
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.